Actinium Pharmaceuticals, Inc. (ATNM)

Operating Cash Flow (Statement)

-$22.66M

TTM · Period ending: · USD

ATNM logo

ATNM Operating Cash Flow (Statement)

Latest reported-$22.66M
ATNM Cash from Operations (-$14.03K → -$22.66M)
High-resolution chart · PNG

ATNM operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-24,580,000
-33,072,000
-47,335,000
8,644,000
-20,866,000
-21,617,000
-21,461,449
-20,571,056
-21,553,346
-20,789,237
-18,543,768
-14,348,754
-6,292,416
-5,212,710
539
7,835
-18,783
-13,964
-15,492
-14,034
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.